Together, our study reveals that knockdown of ACACA significantly inhibited intracellular PAOA-induced lipid accumulation, indicating that ACACA may be a promising therapeutic target for NAFLD. Here, ACACA is linked to metabolic dysfunction-associated steatotic liver disease.